Stocks to Watch Today, December 22: Vedanta, Tata Steel, Fortis Healthcare, Varun Beverages in Focus
Stocks to Watch Today: Indian equity markets are expected to open on a positive note on Monday, supported by strong global cues. After losing steam in the previous session, benchmark indices Sensex and Nifty 50 are likely to begin trade higher. Early indicators showed GIFT Nifty trading around 26,172, up 141.5 points or 0.54%, suggesting a firm start.
Several stocks are expected to remain active during early trade as companies announced key developments related to acquisitions, investments, regulatory updates, stake changes, and order wins. From Vedanta and Tata Steel to Fortis Healthcare and PVR Inox, a broad set of stocks could see increased investor attention.
Key Stocks to Watch:
Inox Clean Energy:
The company acquired Vibrant Energy’s 1,337 MW renewable energy portfolio in a deal estimated at nearly ₹5,000 crore, strengthening its clean energy presence.
Vedanta:
Chairman Anil Agarwal reiterated the company’s commitment to uninterrupted dividend payouts while outlining plans for a $20 billion expansion.
Indian Overseas Bank (IOB):
The government’s stake in the bank declined to 92.44% following a recent offer-for-sale.
Varun Beverages:
The FMCG major completed the acquisition of South Africa-based Twizza for ₹1,118.7 crore, marking a strategic expansion in the African market.
Indian Hotels Company (IHCL):
IHCL approved the sale of its 25.52% stake in Taj GVK Hotels & Resorts to a promoter-group entity at ₹370 per share, transitioning the partnership into a long-term management model.
IRB Infrastructure Developers:
The board cleared related-party contracts for the TOT-17 project, involving operations, maintenance, and project management under a 20-year revenue-linked concession worth up to ₹6,785 crore.
KIMS:
KIMS entered a long-term lease in Chennai to set up a 300-bed super speciality hospital with an investment of ₹300 crore. It also increased its stake in Sarvejana Healthcare to 75.53%.
GE Vernova T&D India:
The company secured a multi-year order for a 2,500 MW HVDC terminal project, boosting its transmission order book.
RITES:
RITES signed an MoU with the Government of Botswana to support the development and modernization of transport infrastructure.
Granules India:
The US FDA completed an inspection at its Hyderabad facility with five procedural observations. The company clarified that none relate to product safety or data integrity.
Soma Textile & Industries:
The firm received construction orders worth ₹281.18 crore for an expressway project linked to Samruddhi Mahamarg.
Tata Chemicals:
Its subsidiary signed an agreement to acquire 100% stake in Singapore-based Novabay for €25 million, subject to regulatory approvals.
Tata Steel:
The company infused $150 million into its overseas subsidiary. Separately, it received a CGST tax demand totaling over ₹1,100 crore, including penalties.
Indraprastha Gas:
The company formed a joint venture to develop compressed biogas and biofuel projects.
Balkrishna Industries:
The board approved the reappointment of Arvind Poddar as Chairman and Managing Director for five years starting August 2026.
Emmvee Photovoltaic Power:
Its subsidiary commenced operations of a new 2.5 GW solar module manufacturing line in Bengaluru, raising total capacity to 10.3 GW.
Jupiter Wagons:
Promoter Tatravagonka AS acquired an additional 0.55% stake via open market transactions worth ₹135 crore.
Fortis Healthcare:
Fortis signed agreements to acquire People Tree Hospital in Bengaluru for ₹430 crore, with further investments planned to expand capacity beyond 300 beds.
KEC International:
The High Court stayed Power Grid Corporation’s order, allowing KEC to participate in ongoing and future bids pending case proceedings.
PVR Inox:
The company opened a new two-screen multiplex in Leh, Ladakh, expanding its footprint to 1,774 screens across 112 cities.
REC:
REC Power Development incorporated Musalgaon Power Transmission as a wholly owned subsidiary.
Vidya Wires:
Vidya Wires is set to declare its quarterly earnings on December 22. The announcement will be closely tracked by investors as it reflects the company’s performance after its recent stock market listing.
Sudeep Pharma:
Sudeep Pharma will also report its Q2 consolidated year-on-year financial results today. Market participants will be watching the numbers to assess the company’s operational momentum following its market debut.
(Disclaimer: The content above is provided solely for informational purposes and should not be treated as investment advice. SmartInvestment advises readers to consult a qualified financial advisor before making any investment or money-related decisions.)